DESITIN PHARMA A/S

CVR 19389006 · Public limited company (A/S) · Active · Low risk

DESITIN PHARMA A/S is a Public limited company (A/S), founded on , based in København V. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (30 Sep 2025) shows equity of DKK 7.0m and a net result of DKK 289k. CEO: Eli Lønne.

Bankruptcy risk for DESITIN PHARMA A/S

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 18% of active Danish companies

Lowest riskHighest risk

Increases the risk

Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Annual reports filed late2 · bankruptcy rate 10.4%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×
Employees (latest year)5–10 · bankruptcy rate 10.1%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
19389006
Status
Active
Company type
Public limited company (A/S)
Founded
(30 years)
Address
Rådhuspladsen 16
1550 København V
Municipality
København
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 500k
Employees
5 (2018)
Auditor
Beierholm Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late2 of 29
Missing annual reportNo
Negative equityNo
Equity ratio91.3%
Current ratio1,146%
Moves (last 2 years)1
CEO changes in total7
CEO's previous bankruptcies0
Other companies at the address170
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 2.2mDKK 2.2m
Net profitDKK 289kDKK 286k
EquityDKK 7.0mDKK 6.8m
Total assetsDKK 7.7mDKK 7.2m
CashDKK 7.2m–
Short-term debtDKK 668k–
Tax owedDKK 52k–
Avg. employees2–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
1 Oct 2024 – 30 Sep 202548
1 Oct 2023 – 30 Sep 202435
1 Oct 2022 – 30 Sep 202358
1 Oct 2021 – 30 Sep 2022146
1 Oct 2020 – 30 Sep 2021140
1 Oct 2019 – 30 Sep 202062
1 Oct 2018 – 30 Sep 201936
1 Oct 2017 – 30 Sep 201825
1 Oct 2016 – 30 Sep 201771
1 Oct 2015 – 30 Sep 201663
1 Oct 2014 – 30 Sep 201581
1 Oct 2013 – 30 Sep 2014167
1 Oct 2012 – 30 Sep 201377
1 Oct 2011 – 30 Sep 201247
1 Oct 2010 – 30 Sep 201154
1 Oct 2009 – 30 Sep 201063
1 Oct 2008 – 30 Sep 200964
1 Oct 2007 – 30 Sep 200840
1 Oct 2006 – 30 Sep 2007164
1 Oct 2005 – 30 Sep 200652

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOEli LønneCurrent
CEODieter Heinrich Peitz
CEOHans-Jurgen Tacke
CEOSøren Lars Mikkelsen
CEOAlexander Arnkværn Berg
BoardEli LønneCurrent
BoardPhilipp Andreas BlochingCurrent
BoardOliver ChristophCurrent
BoardDieter Heinrich Peitz
BoardHans-Jurgen Tacke
BoardMichael Hanke
BoardMichael Hanke
BoardTina Nørgaard
BoardMartin Schütt
BoardChristian Eric Schmolck
BoardAlexander Arnkværn Berg
BoardChristoph Steinschulte
BoardKatrin Elisabeth Thieken
Owner (100%)Desitin Arzneimittel GmbHCurrent
AuditorBeierholm Godkendt RevisionspartnerselskabCurrent
AuditorCJ Partnership I/S
AuditorMUNGIS A/S
AuditorJ&P Invest, Kbh. ApS
AuditorEMIT P/S
FounderDesitin Arzneimittel GmbHCurrent

The CEOs' other companies

Søren Lars Mikkelsen – 4 other companies

Address history (3 moves)

Rådhuspladsen 16, 1550 København V
Automatikvej 1, 4., 2860 Søborg
Havnegade 55, st. tv, 1058 København K
Nyhavn 43B, 1051 København K

Employees per year

Number of employees at DESITIN PHARMA A/S per year362011: 520112012: 620122013: 520132014: 520142015: 520152016: 520162017: 420172018: 52018

Other companies at the same address

Similar companies in København

Questions and answers about DESITIN PHARMA A/S

Has DESITIN PHARMA A/S gone bankrupt?

No, DESITIN PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of DESITIN PHARMA A/S?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of DESITIN PHARMA A/S?

Eli Lønne is the CEO of DESITIN PHARMA A/S.

Who is the auditor of DESITIN PHARMA A/S?

DESITIN PHARMA A/S most recently used Beierholm Godkendt Revisionspartnerselskab.

When was DESITIN PHARMA A/S founded?

DESITIN PHARMA A/S was founded on 1 July 1996.

What is the equity of DESITIN PHARMA A/S?

Equity was DKK 7.0m according to the annual report for the period ending 30 September 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.